We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.5B
AUM Growth
-$232M
Cap. Flow
-$540M
Cap. Flow %
-2.92%
Top 10 Hldgs %
27.76%
Holding
3,069
New
24
Increased
234
Reduced
2,759
Closed
38

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$41.7M
2
DOCU
DocuSign
DOCU
+$18.2M
3
APO icon
Apollo Global Management
APO
+$17.5M
4
FLEX icon
Flex
FLEX
+$16.1M
5
WDAY icon
Workday
WDAY
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 29.77%
2 Financials 13.35%
3 Consumer Discretionary 11.87%
4 Industrials 10.17%
5 Healthcare 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDNW
2851
RideNow Group
RDNW
$220M
$46.3K ﹤0.01%
8,521
-64
-0.7% -$355
STEM icon
2852
Stem
STEM
$45.4M
$45.5K ﹤0.01%
3,774
-285
-7% -$2.45K
SLDB icon
2853
Solid Biosciences
SLDB
$933M
$45.4K ﹤0.01%
11,349
-857
-7% -$4.71K
CPSS icon
2854
Consumer Portfolio Services
CPSS
$203M
$44.9K ﹤0.01%
4,137
-404
-9% -$4.14K
ANRO icon
2855
Alto Neuroscience
ANRO
$1.26B
$44.9K ﹤0.01%
10,620
-802
-7% -$5K
DIBS icon
2856
1stdibs.com
DIBS
$146M
$44.8K ﹤0.01%
12,645
-954
-7% -$3.86K
CSTE icon
2857
Caesarstone
CSTE
$110M
$43.7K ﹤0.01%
10,289
-777
-7% -$3.42K
LVWR icon
2858
LiveWire
LVWR
$234M
$43.5K ﹤0.01%
9,048
-683
-7% -$4.02K
TPIC
2859
DELISTED
TPI Composites
TPIC
$43.3K ﹤0.01%
22,924
-1,731
-7% -$4.81K
HBIO icon
2860
Harvard Bioscience
HBIO
$36.6M
$42.8K ﹤0.01%
2,026
-153
-7% -$3.51K
VERU icon
2861
Veru
VERU
$41.6M
$42.7K ﹤0.01%
6,567
-496
-7% -$3.68K
OPRX icon
2862
OptimizeRx
OPRX
$137M
$42.4K ﹤0.01%
8,734
-659
-7% -$3.68K
BDTX icon
2863
Black Diamond Therapeutics
BDTX
$114M
$42.3K ﹤0.01%
19,774
-1,494
-7% -$4.28K
COLD icon
2864
Americold
COLD
$4.17B
$42.3K ﹤0.01%
1,975
-140
-7% -$3.39K
LXRX icon
2865
Lexicon Pharmaceuticals
LXRX
$890M
$42.2K ﹤0.01%
57,082
-4,309
-7% -$5.19K
EVI icon
2866
EVI Industries
EVI
$205M
$42K ﹤0.01%
2,567
-194
-7% -$3.7K
GYRE icon
2867
Gyre Therapeutics
GYRE
$714M
$42K ﹤0.01%
3,468
-262
-7% -$3.35K
BZ icon
2868
Kanzhun
BZ
$7.36B
$42K ﹤0.01%
3,040
-360
-11% -$5.3K
ELAN icon
2869
Elanco Animal Health
ELAN
$11.6B
$41.4K ﹤0.01%
3,422
-243
-7% -$3.18K
CVGI icon
2870
Commercial Vehicle Group
CVGI
$129M
$41.3K ﹤0.01%
16,665
-1,257
-7% -$3.36K
COOK icon
2871
Traeger
COOK
$138M
$41.1K ﹤0.01%
344
-22
-6% -$3.38K
APLT
2872
DELISTED
Applied Therapeutics
APLT
$40.9K ﹤0.01%
47,798
-3,608
-7% -$22.6K
RDZN icon
2873
Roadzen
RDZN
$97.1M
$40.9K ﹤0.01%
18,769
+10,680
+132% +$13.2K
OMF icon
2874
OneMain Financial
OMF
$7.22B
$40.9K ﹤0.01%
784
-56
-7% -$2.9K
NAUT icon
2875
Nautilus Biotechnolgy
NAUT
$130M
$40.7K ﹤0.01%
24,222
-1,828
-7% -$4.37K

Similar funds

Corebridge Financial's Q4 2024 Portfolio in Review

As of Q4 2024, Corebridge Financial held 3,069 positions worth $18.5B, down 1.2% from $18.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 2%. Corebridge Financial opened 24 new positions and exited 38, leaving the 3,069-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Corebridge Financial's largest Q4 2024 buy was Apollo Global Management: 110,177 shares worth $18.2M.
  • Corebridge Financial added most to iShares MSCI EAFE ETF in Q4 2024, an estimated $41.7M increase.
  • Corebridge Financial's biggest Q4 2024 reduction was Apple, cutting an estimated $36.8M.
  • Corebridge Financial fully exited Southwestern Energy Company in Q4 2024, selling an estimated $9.27M.
  • Corebridge Financial's ten largest holdings make up 28% of its $18.5B portfolio in Q4 2024.
  • Corebridge Financial opened 24 new positions and closed 38 in Q4 2024.
  • Corebridge Financial's portfolio value fell 1.2% quarter-over-quarter to $18.5B.

Based on Corebridge Financial's 13F filing for Q4 2024, filed 11 Feb 2025.